Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30053663HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30020614HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30053664HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30053665HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30053666HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30053667HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30053668HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30053669HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30053670HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30053671HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TCGA Plot Options
Drug Information
GeneTOP1
DrugBank IDDB06159
Drug NameRubitecan
Target IDBE0000971
UniProt IDP11387
Regulation Type
PubMed IDs16193332
CitationsChedid S, Rivera E, Frye DK, Ibrahim N, Esteva F, Valero V, Hortobagyi G, Mettinger KL, Cristofanilli M: Minimal clinical benefit of single agent Orathecin (Rubitecan) in heavily pretreated metastatic breast cancer. Cancer Chemother Pharmacol. 2006 Apr;57(4):540-4. Epub 2005 Sep 29.
GroupsInvestigational
Direct Classification
SMILESCC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C1N=C1C=CC=C(C1=C3)[N+]([O-])=O)C2=O
Pathways
PharmGKB
ChEMBLCHEMBL77305